|Age:||1 years or older|
|Keywords:||Neuroblastoma, Progressive Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma, childhood cancer, pediatric cancer|
|Type:||Biological study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
= 16 years (male 1.7 mg/dL, female 1.4 mg/dL) (within 7 days prior to enrollment).
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.